Japan Health Panel Finds No Causal Link Between Tamiflu, Abnormal Behavior (Japan)
This article was originally published in PharmAsia News
Executive Summary
Researchers at Japan's Ministry of Health, Labor and Welfare found no causal link between Roche's anti-flu drug Tamiflu (oseltamivir phosphate) and incidents of abnormal behavior. The group surveyed physicians and relatives of 10,000 flu patients 18 years old and younger, and found 79.3 percent of them took the drug. The survey disclosed symptoms of abnormal behavior in 9.7 percent of patients given Tamiflu and 22 percent of those who did not take the drug. The leader of the researchers cautioned no conclusion could be made until the results are analyzed further. (Click here for more